Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis

Hua-Song Zeng1, Xiao-Yan Xiong, Yan-Dan Wei

  • 1Department of Allergy, Immunology and Rheumatology, Guangzhou Children's Hospital, Guangzhou 510120, China. huasongz@gmail.com

Insights

Macrophage activation syndrome (MAS) is a severe complication of systemic-onset juvenile idiopathic arthritis (SoJIA). Early recognition and treatment of MAS in children are crucial for reducing mortality rates.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Hematology

Background:

  • Macrophage activation syndrome (MAS) is a life-threatening condition associated with chronic rheumatic diseases, particularly systemic-onset juvenile idiopathic arthritis (SoJIA) in children.
  • MAS presents with diverse clinical and laboratory findings, often lacking specific characteristics, making early diagnosis challenging.

Purpose of the Study:

  • To analyze the clinical and laboratory features of SoJIA patients diagnosed with MAS.
  • To identify key characteristics that aid in the early recognition and management of MAS in pediatric patients.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 13 SoJIA patients with MAS.
  • Data collected from January 2003 to October 2007.

Main Results:

  • The study included 13 patients (9 boys, 4 girls) aged 5 months to 12 years.
  • Common manifestations included persistent fever, anemia, arthritis, hepatosplenomegaly, lymphadenopathy, liver dysfunction, abnormal lipid metabolism, and bone marrow hemophagocytosis.
  • Severe complications such as acute respiratory distress syndrome and multi-organ failure occurred, with a mortality rate of 23% (3 out of 13 patients).
  • Perforin A91V gene analysis in 6 patients showed normal results.
  • Glucocorticoids, immunosuppressive therapy, and plasmapheresis (in one severe case) demonstrated effectiveness.

Conclusions:

  • MAS is a critical complication of juvenile idiopathic arthritis (JIA), especially the systemic-onset form.
  • Prompt diagnosis and timely intervention are essential to improve outcomes and reduce mortality in pediatric MAS patients.
Abstract

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...